Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples by using a monoclonal...

Area of Science:

• Virology
• Immunology
• Biochemistry

Background:

• Human T-cell lymphotropic virus type I (HTLV-I) is associated with serious neurological conditions.
• Accurate and sensitive detection methods for HTLV-I are essential for diagnosis and research.

Purpose of the Study:

• To develop and characterize a highly sensitive and specific enzyme immunoassay (EIA) for detecting the HTLV-I core protein (p19).
• To compare the sensitivity and specificity of the developed EIA with existing methods like reverse transcriptase measurement.

Main Methods:

• Development of a monoclonal antibody (clone 6.11) targeting the HTLV-I p19 gag gene-encoded protein.
• Enzyme immunoassay (EIA) implementation for antigen detection.
• Sensitivity testing using varying amounts of whole-virus lysate.
• Specificity testing against HTLV-II and a panel of other viruses (herpesviruses, measles, HIV).
• Analysis of viral protein localization during density gradient ultracentrifugation.

Main Results:

• The EIA demonstrated over 100-fold greater sensitivity than reverse transcriptase measurement, detecting less than 500 pg of viral lysate.
• The assay showed high type specificity, with no positive signal from HTLV-II antigens.
• No antigenic cross-reactivity was observed with other tested viruses, including herpesviruses, measles virus, and human immunodeficiency viruses.
• Viral p19 was found to associate with viral membrane proteins during ultracentrifugation, distinct from reverse transcriptase activity.

Conclusions:

• The developed monoclonal antibody-based EIA is a highly sensitive and specific tool for detecting HTLV-I core protein.
• This EIA offers significant advantages over traditional methods for HTLV-I detection.
• The assay is effective in detecting HTLV-I antigen in clinical samples from patients with HTLV-I-associated myelopathies and asymptomatic individuals.